<?xml version="1.0" encoding="UTF-8"?>
<p>Thermoresponsive and mucoadhesive hydrogel formulations based on the thermosensitive polymer Pluronic
 <bold>
  <sup>®</sup>
 </bold> 127 and either carboxymethyl cellulose or chitosan were studied in vitro as intranasal sprays in order to optimize their deposition in the nasal cavity, their gel transition at 34 °C (the nasal cavity temperature), and the release profiles of adamantine chosen as a model drug [
 <xref rid="B99-pharmaceutics-10-00039" ref-type="bibr">99</xref>]. Studies performed using an in vitro human nasal airway model evidenced that chitosan can provide the requirements for mucoadhesion in these formulations [
 <xref rid="B99-pharmaceutics-10-00039" ref-type="bibr">99</xref>].
</p>
